LT3435993T - Cyp- eikozanoidų analogas, skirtas naudoti su neovaskuliarizacija ir (arba) uždegimu susijusių sutrikimų gydymui arba jų profilaktikai - Google Patents
Cyp- eikozanoidų analogas, skirtas naudoti su neovaskuliarizacija ir (arba) uždegimu susijusių sutrikimų gydymui arba jų profilaktikaiInfo
- Publication number
- LT3435993T LT3435993T LTEPPCT/EP2017/057830T LTEP2017057830T LT3435993T LT 3435993 T LT3435993 T LT 3435993T LT EP2017057830 T LTEP2017057830 T LT EP2017057830T LT 3435993 T LT3435993 T LT 3435993T
- Authority
- LT
- Lithuania
- Prior art keywords
- eicosanoid
- cyp
- neovascularization
- prophylaxis
- analogue
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662317253P | 2016-04-01 | 2016-04-01 | |
| EP17153412 | 2017-01-26 | ||
| PCT/EP2017/057830 WO2017168007A1 (en) | 2016-04-01 | 2017-04-03 | Analogs of cyp-eicosanoids for use in treating or preventing a disorder associated with neovascularization and/or inflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT3435993T true LT3435993T (lt) | 2024-12-27 |
Family
ID=65863570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEPPCT/EP2017/057830T LT3435993T (lt) | 2016-04-01 | 2017-04-03 | Cyp- eikozanoidų analogas, skirtas naudoti su neovaskuliarizacija ir (arba) uždegimu susijusių sutrikimų gydymui arba jų profilaktikai |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20190117597A1 (lt) |
| JP (1) | JP6944465B2 (lt) |
| CN (2) | CN119367342A (lt) |
| DK (1) | DK3435993T3 (lt) |
| LT (1) | LT3435993T (lt) |
| MX (1) | MX393427B (lt) |
| SI (1) | SI3435993T1 (lt) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2208720A1 (en) * | 2009-01-13 | 2010-07-21 | Max-Delbrück-Centrum für Molekulare Medizin (MDC) | Novel eicosanoid derivatives |
| IT1393419B1 (it) | 2009-03-19 | 2012-04-20 | Medivis S R L | Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6. |
| GEP20166444B (en) * | 2011-04-06 | 2016-03-10 | Medical College Of Wisconsin | Epoxyeicosatrienoic acid analogs and methods of making and using the same |
| SI3097076T1 (sl) * | 2014-01-22 | 2019-10-30 | Max Delbrueck Centrum Fuer Molekulare Medizin | Novi derivati CYP-eikozanoida |
| ES2952726T3 (es) | 2015-07-22 | 2023-11-03 | Omeicos Therapeutics Gmbh | Análogos metabólicamente fuertes de CYP-eicosanoides para el tratamiento de enfermedad cardíaca |
-
2017
- 2017-04-03 JP JP2018550716A patent/JP6944465B2/ja active Active
- 2017-04-03 LT LTEPPCT/EP2017/057830T patent/LT3435993T/lt unknown
- 2017-04-03 MX MX2018011986A patent/MX393427B/es unknown
- 2017-04-03 CN CN202411437126.5A patent/CN119367342A/zh active Pending
- 2017-04-03 CN CN201780030614.6A patent/CN109562083A/zh active Pending
- 2017-04-03 SI SI201731573T patent/SI3435993T1/sl unknown
- 2017-04-03 DK DK17716149.4T patent/DK3435993T3/da active
- 2017-04-03 US US16/089,461 patent/US20190117597A1/en not_active Abandoned
-
2021
- 2021-07-22 US US17/383,131 patent/US12370158B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP6944465B2 (ja) | 2021-10-06 |
| RU2018133413A3 (lt) | 2020-05-12 |
| CN109562083A (zh) | 2019-04-02 |
| RU2018133413A (ru) | 2020-05-12 |
| MX393427B (es) | 2025-03-24 |
| US20190117597A1 (en) | 2019-04-25 |
| SI3435993T1 (sl) | 2025-03-31 |
| US20210353569A1 (en) | 2021-11-18 |
| CN119367342A (zh) | 2025-01-28 |
| DK3435993T3 (da) | 2024-12-16 |
| MX2018011986A (es) | 2019-07-10 |
| NZ746544A (en) | 2021-10-29 |
| JP2019515887A (ja) | 2019-06-13 |
| US12370158B2 (en) | 2025-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL279752A (en) | Polycyclic compounds and use thereof in the treatment of immune disorders | |
| GB2548873B (en) | Use of Cannabidiol in the Treatment of SturgeWeber Syndrome | |
| LT3240554T (lt) | Blautia stercosis ir wexlerae, skirtos naudoti uždegiminių ir autoimuninių ligų gydymui | |
| LT3325509T (lt) | Anti-tfr antikūnai ir jų panaudojimas proliferacinių ir uždegiminių sutrikimų gydymui | |
| HUE061761T2 (hu) | Tetrahidropiranil-amino-pirrolopirimidinon felhasználásra BTK-által közvetített zavarok kezelésében | |
| LT3250210T (lt) | Kompozicijos ir būdai, skirti gydyti cns sutrikimus | |
| GB202005785D0 (en) | Combinations of lanosterol or 25-hydroxycholesterol including derivatives thereof useful in the treatment of lens disorders | |
| DK3362449T3 (da) | Sibirilin-derivater til anvendelse til at forebygge og/eller behandle lidelser associeret med cellulær nekroptose | |
| HUE058314T2 (hu) | Pridopidin alkalmazása Rett-szindróma kezelésére | |
| EP3573641A4 (en) | TREATMENT METHODS FOR DISORDERS ASSOCIATED WITH ANGIOGENESIS AND NEOVASCULARIZATION | |
| PL3732294T3 (pl) | Tymohydrochinon do stosowania w leczeniu hiperglikemii | |
| DK3808188T2 (da) | Fiskefoder og fremgangsmåde til smoltifikation og forebyggelse af desmoltifikation hos salmonidae samt til profylakse og behandling af hæmoragisk smoltsyndrom (hss) hos salmonidae | |
| PL3452012T3 (pl) | Kompozycje do leczenia zespołu policystycznych jajników i powiązanych zaburzeń metabolicznych | |
| LT3532064T (lt) | Kompleksiniai gydymai, apimantys imidazopirazonus, skirti psichiatrinių ir (arba) kognityvinių sutrikimų gydymui | |
| IL275349A (en) | Use of hM4Di in the treatment of seizure disorders | |
| SG11202103191QA (en) | Benzimidazole derivative for use in the treatment of inflammatory disorders | |
| IL289371A (en) | Methylthioninium for use in the treatment of synaptopathies | |
| IL274838A (en) | Use of MIR101 or MIR128 in the treatment of seizure disorders | |
| LT3897578T (lt) | Ly3154207 dozavimo režimai gydant dopaminerginius cns sutrikimus | |
| ZA202006886B (en) | R-fadrozole for use in the treatment of aldostonerism | |
| IL276697A (en) | 3 Beta-(4-methoxybenzyloxy)paragan-5-en-20-one for use in the treatment of cannabinoid-related disorders | |
| LT3752253T (lt) | Kompozicija, skirta plaukų augimo sutrikimų profilaktikai ir gydymui | |
| ZA201806894B (en) | (+)-azasetron for use in the treatment of ear disorders | |
| PL3618806T3 (pl) | Kompozycja do leczenia aft i owrzodzeń jamy ustnej | |
| DK3484476T3 (da) | Meclozin-derivater til anvendelse ved forebyggelse og/eller behandling af lidelser associeret med den forårsagede inflammation |